Study to Assess Efficacy and Safety of PF-06947386 in Japanese Adult Patients With Complicated Intra-abdominal Infection
Status:
Recruiting
Trial end date:
2022-08-31
Target enrollment:
Participant gender:
Summary
Study C3591036 is a Phase 3 study to assess the efficacy and safety of PF-06947386 in
Japanese adult patients with complicated intra-abdominal infection requiring hospitalization.
This is a multicenter, open-label, single-arm study. All eligible participants will receive
intravenous infusion of PF-06947386 followed by intravenous infusion of metronidazole.